IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

List of Oncology Medication For

Leukemia

Indian Pharma Network

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

ANAGRELIDE Capsules

anagrelide hydrochloride Dosage Form: 0.5 mg capsules for oral

Generic Name: Anagrelide Hydrochloride
Strength: 0.5 mg and 1 mg
Dosage Form: Capsule

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import ANAGRELIDE Capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

asciminib tablets

asciminib tablets
for oral use Initial U.S. Approval: 2021

Scemblix (asciminib) is a prescription medication used to treat adults with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP).

Facts about asciminib tablets

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Novartis
USAGE-Film-coated tablets: 20 mg and 40 mg
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “asciminib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

asparaginase erwinia chrysanthemi injection

asparaginase erwinia chrysanthemi (recombinant) rywn) injection, for intramuscular use Initial U.S. Approval: 2021

Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) is a prescription medicine that is a component of a multi-agent chemotherapeutic regimen used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in adults and children aged 1 month or older who have developed hypersensitivity to E. coli-derived asparaginase.

Facts about asparaginase erwinia chrysanthemi injection

Disease Indications-Leukemia, Lymphoma
Manufacturer-Jazz Pharmaceuticals
Usage-Intravenous
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “asparaginase erwinia chrysanthemi injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

azacitidine injection

azacitidine for injection
for SC or IV use Initial U.S. Approval: 2004

As specified in the prescribing information, azacitidine injection is indicated for the treatment of Leukemia.  Onureg (azacitidine) is a medication used for the continued treatment of adults with acute myeloid leukemia (AML).

Facts about azacitidine injection

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Celgene
USAGE-Oral
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “azacitidine injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Blinatumomab For Injection

Blinatumomab For Injection
for intravenous use Initial U.S. Approval: 2014

Blinatumomab For Injection is “used to treat adults and children with: • B-cell precursor acute lymphoblastic leukemia (ALL)“. BLINCYTO for injection is aprescription medicine”. It is available in “form and strength” For injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution.  BLINCYTO for injection can be obtained in India upon request.
To inquire about the BLINCYTO (blinatumomab) for injection “offer price in India”, “shipping process”, and the “estimated time of availability in India”, please get in touch at +91 9891 296 838 (Mr. Tarun) / +91 9811 747 774 (Mr. Neeraj). with the IPN Delhi healthcare team for further discussion.”

Facts about your medicine

Approval Date: 2014
Proprietary Name: On Request
Active Ingredient(s): Blinatumomab for injection
Dosage Forms And Strengths: For injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution. 
Manufacturer: Amgen Inc
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

read more

BLINCYTO (blinatumomab) for Injection

Blincyto is a prescription only medicine, which is used in treating patients with B-cell precursor acute lymphoblastic leukemia in first or second complete remission with minimal residual disease greater than or equal 0.1% and relapsed or refractory B-cell precursor ALL (Acute Lymphoblastic Leukemia). Blincyto is the trade name for the drug Blinatumomab. Blincyto® is approved by the FDA. Date of approval: 2014. Blincyto® is available as 35 mcg of lyophilized powder in a single-use vial for reconstitution.

Name: BLINCYTO
Generic Name: Blinatumomab
Strength: 35 mcg | 38.5 Single-Dose Vial
Manufactured : Amgen Inc

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import BLINCYTO (blinatumomab) for Injection ” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.2

read more

bosutinib tablets

bosutinib tablets
for oral use Initial U.S. Approval: XXXX

Bosulif (bosutinib) is a medication used for the treatment of chronic myeloid leukaemia (CML) in adults with the Philadelphia chromosome (Ph+). It is used to treat adult patients with newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML) or with chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy.

Facts about bosutinib-tablets

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Pfizer Limited
USAGE-Tablets: 100 mg and 500 mg
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

calaspargase pegol-mknl injection

calaspargase pegol -mknl injection
for intravenous use Initial U.S. Approval: 2018

Asparlas (calaspargase pegol-mknl) is a component of a multiagent chemotherapeutic regimen for the treatment of Acute Lymphoblastic Leukemia (ALL) in pediatric and young adult patients aged 1 month to 21 years.

Facts about calaspargase pegol -mknl injection

DISEASE INDICATIONS-Leukemia
MANUFACTURER-Servier
USAGE-Intravenous
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

COTELLIC (cobimetinib) Tablets

The Cotellic specifically contains the active substance Cobimetinib. The cobimetinib 20 mg specifically belongs to the kinase inhibitors class of drug. Falls under the kinase inhibitor class of drug, cobimetinib acts in order to block the action of an abnormal protein that signals cancer cells to multiply. This helps resist or block the spread of cancerous cells.

Brand Name: Cotellic
Innovator Brand Name: Cotellic
API: Cobimetinib Fumarate
Packaging: 63 Tablets
Strength: 20mg
Manufacturer Name: Genentech

Access Patient Name Basis Treatment

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import COTELLIC (cobimetinib) Tablets ” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Dasatinib Tablets

dasatinib Tablet
for Oral Use Initial U.S. Approval: 2006

SPRYCEL is a kinase inhibitor indicated for the treatment of • newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Facts about Dasatinib Tablets

Approval Date: 2006
Proprietary Name: On Request
Active Ingredient(s): Dasatinib Tablets
Dosage Forms And Strengths: Tablets: 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
Company: Bristol-Myers Squibb
Current indications: chronic Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML)
Medicine Approved By: –
 European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “Dasatinib Tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

read more

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398